Anti-4-1BB-based immunotherapy for autoimmune diabetes: lessons from a transgenic non-obese diabetic (NOD) model

By Sytwu H.-K.   Lin W.-D.   Roffler S.R.   Hung J.-T.   Sung H.-S.   Wang C.-H.   Cheng T.-L.   Tsou S.-C.   Hsi S.-C.   Shen K.-L.  

Journal of Autoimmunity, Vol. 21, Iss. 3, 2003-11 ,pp. : 247-254

Elsevier

Access to resources Recommend Favorite

Dominant Role of Intercellular Adhesion Molecule-1 in the Pathogenesis of Autoimmune Diabetes in Non-obese Diabetic Mice

By Martin S.   van den Engel N.K.   Vinke A.   Heidenthal E.   Schulte B.   Kolb H.  

Journal of Autoimmunity, Vol. 17, Iss. 2, 2001-09 ,pp. : 109-117

Academic Press

Access to resources Recommend Favorite

Dysregulated Toll-like receptor expression and signaling in bone marrow-derived macrophages at the onset of diabetes in the non-obese diabetic mouse

By Mohammad Mohammad K.   Morran Michael   Leaman Douglas W.   Sun Yaping   Grafenstein Hermann von   Hong Soon-Cheol   McInerney Marcia F.  

International Immunology, Vol. 18, Iss. 7, 2006-07 ,pp. : 1101-1113

Oxford University Press

Access to resources Recommend Favorite

Dysregulated Toll-like receptor expression and signaling in bone marrow-derived macrophages at the onset of diabetes in the non-obese diabetic mouse

By  

International Immunology, Vol. 19, Iss. 4, 2007-04 ,pp. : 581-581

Oxford University Press

Access to resources Recommend Favorite

Prophylactic fenbendazole therapy does not affect the incidence and onset of type 1 diabetes in non-obese diabetic mice

By Franke Deanna D. H.   Shirwan Haval  

International Immunology, Vol. 18, Iss. 3, 2006-03 ,pp. : 453-458

Oxford University Press

Access to resources Recommend Favorite